Investors target Chinese cancer drugs
Drug developers such as I-Mab are trying to lead the market and secure future cash flow with their technological progress.
March 08, 2019
- News
-
Investment Lifecycle
Deals & Trends
Rainmakers
Regions
- Research
-
- Awards
-
- Events
- Photo Gallery
